Home > Insider Trading > Filing (0001420295-12-000002)

Filing Details

Accession Number:: 0001420295-12-000002
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-12-21 18:21:45
Reporting Period:: 2012-12-19

Filing Date:: 2012-12-21
Accepted Time:: 2012-12-21 18:21:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1381197	Interactive Brokers Group Inc.	IBKR	Security Brokers, Dealers & Flotation Companies (6211)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1361345	Tcv Member Fund, L.p.	C/O Technology Crossover Ventures 528 Ramona Street Palo Alto CA 94301	No	No	No	Yes
1406509	David Yuan	C/O Technology Crossover Ventures 528 Ramona Street Palo Alto CA 94301	No	No	No	Yes
1406576	C. John Rosenberg	C/O Technology Crossover Ventures 528 Ramona Street Palo Alto CA 94301	No	No	No	Yes
1419272	P L Vii(A) Tcv	C/O Technology Crossover Ventures 528 Ramona Street Palo Alto CA 94301	No	No	No	Yes
1420295	Tcv Vii Lp	C/O Technology Crossover Ventures 528 Ramona Street Palo Alto CA 94301	No	No	No	Yes
1440008	P Christopher Marshall	C/O Technology Crossover Ventures 528 Ramona Street Palo Alto CA 94301	No	No	No	Yes
1466999	Technology Crossover Management Vii, Ltd.	C/O Technology Crossover Ventures 528 Ramona Street Palo Alto CA 94301	No	No	No	Yes
1467001	Technology Crossover Management Vii, L.p.	C/O Technology Crossover Ventures 528 Ramona Street Palo Alto CA 94301	No	No	No	Yes
1498115	P Timothy Mcadam	C/O Technology Crossover Ventures 528 Ramona Street Palo Alto CA 94301	No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-12-19	45,793	$14.16	2,243,842	No	4	S	Indirect	TCV VII, L.P.
Common Stock	Disposition	2012-12-19	23,781	$14.16	1,165,280	No	4	S	Indirect	TCV VII (A), L.P.
Common Stock	Disposition	2012-12-19	667	$14.16	32,667	No	4	S	Indirect	TCV Member Fund, L.P.
Common Stock	Disposition	2012-12-20	91,586	$14.12	2,152,256	No	4	S	Indirect	TCV VII, L.P.
Common Stock	Disposition	2012-12-20	47,562	$14.12	1,117,718	No	4	S	Indirect	TCV VII (A), L.P.
Common Stock	Disposition	2012-12-20	1,333	$14.12	31,334	No	4	S	Indirect	TCV Member Fund, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	TCV VII, L.P.
No	4	S	Indirect	TCV VII (A), L.P.
No	4	S	Indirect	TCV Member Fund, L.P.
No	4	S	Indirect	TCV VII, L.P.
No	4	S	Indirect	TCV VII (A), L.P.
No	4	S	Indirect	TCV Member Fund, L.P.

Footnotes

The price reported reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $14.0900 to $14.3650. The Reporting Persons hereby undertake to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
This Form 4 is filed by more than one Reporting Person and is a joint filing with the Form 4 filed by Jay C. Hoag, Richard H. Kimball, John L. Drew, Jon Q. Reynolds, Jr. and Robert W. Trudeau (collectively, the "TCM VI Members"), TCV VI, L.P. and Technology Crossover Management VI, L.L.C. ("TCM VI") on December 21, 2012.
These securities are directly held by TCV VII, L.P. Christopher P. Marshall, Timothy P. McAdam, John C. Rosenberg and David L. Yuan and each of the TCM VI Members (collectively, the "TCM VII Directors") are Class A Directors of Technology Crossover Management VII, Ltd. ("TCM VII") and limited partners of Technology Crossover Management VII, L.P. ("Management VII"). TCM VII is the general partner of Management VII, which is the general partner of TCV VII, L.P. The TCM VII Directors, TCM VII and Management VII may be deemed to beneficially own the securities held by TCV VII, L.P., but the TCM VII Directors, TCM VII and Management VII disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
These securities are directly held by TCV VII (A), L.P. The TCM VII Directors are Class A Directors of TCM VII and limited partners of Management VII. TCM VII is the general partner of Management VII, which is the general partner of TCV VII (A), L.P. The TCM VII Directors, TCM VII and Management VII may be deemed to beneficially own the securities held by TCV VII (A), L.P., but the TCM VII Directors, TCM VII and Management VII disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
These securities are directly held by TCV Member Fund, L.P. ("TCV MF"). The TCM VII Directors are Class A Directors of TCM VII, which is a general partner of TCV MF, and limited partners of TCV MF. The TCM VI Members are Class A Members of TCM VI, which is also a general partner of TCV MF. The TCM VII Directors, TCM VII, the TCM VI Members and TCM VI may be deemed to beneficially own certain of the securities held by TCV MF, but the TCM VII Directors, TCM VII, the TCM VI Members and TCM VI disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
The price reported reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $13.9700 to $14.2300. The Reporting Persons hereby undertake to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.